Drug Search Results
More Filters [+]

Phenobarbital sodium

Alternative Names: phenobarbital sodium
Latest Update: 2024-06-12
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: GABA Activator

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Belgium | Chile | France | Hong Kong | Indonesia | Japan | Pakistan | Sri Lanka | Taiwan | Thailand | United Kingdom | United States | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: PharPoint Research
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Phenobarbital sodium

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Epilepsy, Benign Neonatal|Seizures

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

MI-5780

P3

Terminated

Epilepsy, Benign Neonatal

2023-02-01

NCT03602118

P3

Withdrawn

Seizures

2021-05-01

71%

Recent News Events